| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | -88,006 | -117,294 |
| Depreciation and amortization (inclusive of depreciation included in cost of revenue) | 119,370 | 79,742 |
| Non-cash interest expense and other | -1,825 | -1,217 |
| Increase in allowance for credit losses and sales credits | 2,753 | 5,746 |
| Provision for deferred income taxes | -16,883 | -33,762 |
| Share-based compensation | 24,921 | 18,208 |
| Loss on disposal or impairment of long-lived assets | -18,294 | -18,296 |
| Gain on sale of disposal group | 39,180 | - |
| Net loss (gain) on investments in available-for-sale securities | 69 | 29 |
| Goodwill impairment loss | 109,515 | 109,515 |
| Net loss (gain) on deferred compensation balances | -2,221 | -1,063 |
| Non-cash lease expense | -324 | 41 |
| Accounts receivable | -40,321 | -40,660 |
| Accounts receivable, subcontractor | -18,871 | -11,379 |
| Income taxes receivable | 4,542 | -1,091 |
| Prepaid expenses | -4,325 | -3,802 |
| Other current assets | -5,928 | 4,837 |
| Other assets | -4,469 | -3,645 |
| Accounts payable and accrued expenses | -11,284 | -6,756 |
| Accrued compensation and benefits | -11,054 | -19,566 |
| Other liabilities | 9,947 | 52,080 |
| Deferred revenue | 2,467 | 6,978 |
| Net cash provided by operating activities | 193,885 | 171,219 |
| Purchase and development of fixed assets | 27,683 | 19,775 |
| Purchase of investments | 35,082 | 34,119 |
| Proceeds from sale and maturity of investments | 9,778 | 7,239 |
| Proceeds from sale of disposal group | 65,320 | - |
| Payments to fund deferred compensation plan | 6,125 | 3,256 |
| Proceeds from settlements of company-owned life insurance policies | 6,147 | 3,274 |
| Cash received for working capital settlement of prior year acquisition | 0 | 0 |
| Net cash provided by (used in) investing activities | 12,355 | -46,637 |
| Payments on revolving credit facility | 285,000 | 185,000 |
| Proceeds from revolving credit facility | 75,000 | 45,000 |
| Payment of financing costs | 948 | - |
| Cash paid for shares withheld for taxes | 1,703 | 1,437 |
| Net cash used in financing activities | -212,651 | -141,437 |
| Effect of exchange rate changes on cash | 0 | - |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -6,411 | -16,855 |
| Cash and cash equivalents at beginning of period | 89,305 | - |
| Cash and cash equivalents at end of period | 82,894 | - |
AMN HEALTHCARE SERVICES INC (AMN)
AMN HEALTHCARE SERVICES INC (AMN)